Condition
Inflammatory Bowel Disease (Crohn' clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Inflammatory Bowel Disease (Crohn' clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Germany (1), Taiwan (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Inflammatory Bowel Disease (Crohn' clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Familial IBD Early Risk | — | Seattle, Washington | Recruiting | Aug 28, 2026 |
| Modafinil for Debilitating Fatigue in Quiescent IBD | Phase 2/3 | Arnhem, Gelderland and 1 other locations | Recruiting | May 12, 2026 |
| Traditional Chinese Medicine diagnostics and tongue-coating metabolomics to characterize inflammatory bowel disease | — | Taichung, North | Recruiting | Jan 2, 2026 |
| Molecular Inflammation Board for personalized care of chronic inflammatory diseases | — | Tübingen | Recruiting | Aug 20, 2025 |
| Measuring Calprotectin Levels in Stool for Diagnosing Inflammatory Bowel Disease | — | Miami, Florida and 2 other locations | Recruiting | Feb 5, 2025 |
All recruiting trials (5)
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Modafinil for Debilitating Fatigue in Quiescent IBD
A study will test whether modafinil can help adults with Crohn’s disease or ulcerative colitis who feel very fatigued even when their IBD is quiet.
-
Traditional Chinese Medicine diagnostics and tongue-coating metabolomics to characterize inflammatory bowel disease
This study will test whether TCM diagnostic tools and tongue-coating metabolomics can identify characteristic signs in adults with Crohn's disease or ulcerative colitis compared with people without IBD.
-
Molecular Inflammation Board for personalized care of chronic inflammatory diseases
This project collects clinical, lab, imaging, and patient-reported data from adults with psoriasis, psoriatic arthritis, spondyloarthritis, or inflammatory bowel disease who are referred to the Molecular Inflammation Board to see if the board's recommendations influence care and outcomes.
-
Measuring Calprotectin Levels in Stool for Diagnosing Inflammatory Bowel Disease
This study is testing a new stool test to see if it can help doctors diagnose Inflammatory Bowel Diseases like Crohn's and Ulcerative Colitis more accurately.
Related topics
Quick answers
How many Inflammatory Bowel Disease (Crohn' clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Germany (1 trial), Taiwan (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.